Shat­tuck Labs is lay­ing off 40% of its work­force and dis­con­tin­u­ing its CD47 pro­gram in acute myeloid leukemia and ...

There's major money behind efforts to speed the next significant obesity company to the market. First, it was Metsera, which ...

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced ...

IGM Biosciences will stop working in cancer and shrink its T cell engager pipeline to focus on autoimmune diseases, the ...

A New York federal judge dismissed allegations on Monday that Bristol Myers Squibb purposely delayed Breyanzi’s approval to ...

A court ruling Friday will open the door to the FDA more tightly regulating stem cell clinics and a commonly-used stem cell ...

As the potential end of Robert Califf's time as FDA commissioner nears, he and a key deputy are continuing to push forward ...

California Gov. Gavin Newsom vetoed bipartisan legislation on Saturday that would have reformed pharmacy benefit managers in ...

Johnson & Johnson has called off plans to implement a new rebate model for 340B drug price discounts following threats from ...

Pfizer will continue shrinking its ownership in the British consumer health company Haleon, according to an announcement ...

Ge­nom­ic med­i­cines start­up En­so­ma is shut­ter­ing its Copen­hagen site and al­so elim­i­nat­ing “a very small num­ber” ...

Poseida Therapeutics said that 21 of 23 patients (91%) responded to the allogeneic CAR-T therapy it’s developing with Roche ...